APA (7th ed.) Citation

JC, S., D, C., D, F., D, S., J, T., D, H., . . . L, V. M. (2026). Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccination. Vaccine, 80, 128543. https://doi.org/10.1016/j.vaccine.2026.128543

Chicago Style (17th ed.) Citation

JC, Sirard, et al. "Toll-like Receptor 5 Agonist Is a Potent Adjuvant for Intradermal Vaccination." Vaccine 80 (2026): 128543. https://doi.org/10.1016/j.vaccine.2026.128543.

MLA (9th ed.) Citation

JC, Sirard, et al. "Toll-like Receptor 5 Agonist Is a Potent Adjuvant for Intradermal Vaccination." Vaccine, vol. 80, 2026, p. 128543, https://doi.org/10.1016/j.vaccine.2026.128543.